50.8 |
203.2 |
GO:0090299 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
12.0 |
84.2 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
10.4 |
31.3 |
GO:2000777 |
positive regulation of oocyte maturation(GO:1900195) negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
9.8 |
48.8 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
9.3 |
27.9 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
8.9 |
26.8 |
GO:0018307 |
enzyme active site formation(GO:0018307) tRNA thio-modification(GO:0034227) |
8.6 |
25.8 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
8.4 |
25.3 |
GO:0071988 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
8.1 |
40.4 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
7.2 |
50.7 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
6.1 |
24.3 |
GO:0060613 |
fat pad development(GO:0060613) |
6.1 |
18.2 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
5.6 |
39.4 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
5.6 |
22.4 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
5.4 |
32.7 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
4.5 |
22.4 |
GO:2000638 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
4.2 |
12.7 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
4.1 |
49.0 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
3.6 |
21.4 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
3.5 |
17.4 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
3.3 |
10.0 |
GO:0006106 |
fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) |
3.3 |
19.9 |
GO:0051013 |
microtubule severing(GO:0051013) |
3.3 |
9.9 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
3.3 |
19.8 |
GO:0033133 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
3.1 |
55.6 |
GO:0019614 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
3.0 |
8.9 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
3.0 |
8.9 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
2.8 |
24.9 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
2.7 |
8.0 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
2.4 |
109.7 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
2.4 |
7.3 |
GO:1904395 |
retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
2.4 |
4.7 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
2.3 |
16.4 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.3 |
4.6 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
2.3 |
6.8 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
2.3 |
11.3 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
2.2 |
8.7 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
2.1 |
14.9 |
GO:0042791 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
2.1 |
19.2 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
2.1 |
10.4 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) |
1.9 |
24.6 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
1.9 |
9.4 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
1.9 |
5.6 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
1.7 |
18.8 |
GO:0048102 |
autophagic cell death(GO:0048102) |
1.7 |
48.9 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
1.6 |
9.6 |
GO:1903750 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
1.6 |
4.8 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
1.6 |
4.7 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.5 |
15.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
1.5 |
11.9 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
1.5 |
14.8 |
GO:0051612 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.4 |
8.6 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
1.4 |
4.3 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
1.4 |
16.8 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
1.4 |
12.6 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
1.3 |
6.7 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
1.3 |
14.6 |
GO:0022008 |
neurogenesis(GO:0022008) |
1.3 |
16.9 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
1.3 |
30.6 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
1.3 |
25.2 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
1.2 |
9.7 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
1.2 |
2.4 |
GO:0061055 |
myotome development(GO:0061055) |
1.2 |
2.4 |
GO:2001190 |
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
1.2 |
2.4 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
1.2 |
4.7 |
GO:0035625 |
regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) epinephrine secretion(GO:0048242) |
1.1 |
17.1 |
GO:0099514 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.1 |
4.5 |
GO:1904450 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
1.1 |
10.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.1 |
8.9 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.1 |
52.5 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
1.1 |
6.5 |
GO:0010615 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.1 |
3.2 |
GO:0061074 |
regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
1.1 |
6.4 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
1.0 |
2.1 |
GO:0061511 |
centriole elongation(GO:0061511) |
1.0 |
8.3 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
1.0 |
8.2 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
1.0 |
15.3 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.9 |
8.5 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
0.9 |
13.8 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
0.9 |
3.6 |
GO:0048511 |
rhythmic process(GO:0048511) |
0.9 |
7.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
0.9 |
15.2 |
GO:0019374 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.9 |
4.4 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.9 |
12.9 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
0.9 |
8.5 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.8 |
5.8 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.8 |
2.4 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
0.8 |
5.5 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
0.8 |
8.6 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.8 |
8.4 |
GO:0015886 |
heme transport(GO:0015886) |
0.8 |
1.5 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 |
4.5 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.7 |
8.9 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.7 |
2.2 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.7 |
4.3 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.7 |
12.8 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.7 |
25.9 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
0.7 |
2.7 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
0.7 |
8.1 |
GO:0008037 |
binding of sperm to zona pellucida(GO:0007339) cell recognition(GO:0008037) cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.7 |
21.7 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
0.7 |
9.1 |
GO:0002021 |
response to dietary excess(GO:0002021) |
0.6 |
3.9 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
0.6 |
6.4 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.6 |
1.3 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) |
0.6 |
1.9 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
0.6 |
3.1 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.6 |
27.4 |
GO:0060612 |
adipose tissue development(GO:0060612) |
0.6 |
7.4 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.6 |
21.3 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
0.6 |
2.4 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
0.6 |
8.7 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 |
4.5 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
0.6 |
8.8 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
0.5 |
3.3 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
0.5 |
6.5 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 |
2.6 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
0.5 |
15.1 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
0.5 |
4.6 |
GO:0051026 |
chiasma assembly(GO:0051026) |
0.5 |
2.5 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
0.5 |
22.1 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
0.5 |
9.2 |
GO:1901663 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.5 |
1.9 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 |
11.2 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
0.5 |
1.9 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
0.5 |
21.9 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
0.4 |
17.0 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
0.4 |
1.3 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 |
1.3 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
0.4 |
2.1 |
GO:0022605 |
ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) |
0.4 |
3.2 |
GO:0070986 |
left/right axis specification(GO:0070986) |
0.4 |
4.0 |
GO:0015871 |
choline transport(GO:0015871) |
0.4 |
7.7 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
0.4 |
8.5 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 |
7.3 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
0.4 |
0.8 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
0.3 |
1.0 |
GO:0044805 |
late nucleophagy(GO:0044805) |
0.3 |
32.3 |
GO:0007286 |
spermatid development(GO:0007286) |
0.3 |
16.6 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
0.3 |
2.7 |
GO:0016926 |
protein desumoylation(GO:0016926) |
0.3 |
6.3 |
GO:0097484 |
dendrite extension(GO:0097484) |
0.3 |
9.3 |
GO:0015695 |
organic cation transport(GO:0015695) |
0.3 |
1.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 |
1.7 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
0.3 |
1.9 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 |
11.4 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 |
7.4 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 |
3.8 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
0.2 |
14.6 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
0.2 |
1.1 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
0.2 |
3.3 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
0.2 |
4.4 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 |
8.3 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
0.2 |
4.1 |
GO:0003334 |
keratinocyte development(GO:0003334) |
0.2 |
2.1 |
GO:0015889 |
cobalamin transport(GO:0015889) |
0.2 |
3.7 |
GO:0071625 |
vocalization behavior(GO:0071625) |
0.2 |
12.5 |
GO:0045839 |
negative regulation of mitotic nuclear division(GO:0045839) |
0.2 |
8.4 |
GO:0046949 |
fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.2 |
5.4 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
0.2 |
3.2 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
0.2 |
6.3 |
GO:0030317 |
sperm motility(GO:0030317) |
0.2 |
11.0 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
0.2 |
11.1 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
0.2 |
7.6 |
GO:1901379 |
regulation of potassium ion transmembrane transport(GO:1901379) |
0.2 |
4.0 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
0.2 |
5.8 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 |
8.4 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
0.2 |
31.5 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
0.2 |
1.8 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.2 |
6.3 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 |
0.7 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 |
4.1 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.2 |
0.8 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
0.2 |
6.1 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
0.2 |
3.7 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
0.2 |
6.3 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
0.2 |
5.4 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
0.2 |
8.3 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 |
1.2 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 |
9.9 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
0.1 |
15.5 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
0.1 |
5.9 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
0.1 |
12.2 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 |
5.3 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 |
8.4 |
GO:0009060 |
aerobic respiration(GO:0009060) |
0.1 |
1.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
0.1 |
0.9 |
GO:0071372 |
response to light intensity(GO:0009642) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 |
1.2 |
GO:0015074 |
DNA integration(GO:0015074) |
0.1 |
5.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
0.1 |
8.1 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 |
3.3 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
0.1 |
0.6 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 |
2.9 |
GO:0060996 |
dendritic spine development(GO:0060996) |
0.1 |
0.4 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
0.1 |
3.7 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
0.1 |
1.0 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 |
4.2 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
0.1 |
0.6 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
0.1 |
1.7 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
0.1 |
2.8 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
0.1 |
1.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 |
0.7 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
0.1 |
0.9 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
0.1 |
0.2 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
0.1 |
2.1 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
0.1 |
1.8 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
0.1 |
1.1 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
0.1 |
4.5 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
0.1 |
1.1 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
0.1 |
1.5 |
GO:0010107 |
potassium ion import(GO:0010107) |
0.1 |
0.5 |
GO:0010727 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 |
1.2 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 |
2.2 |
GO:0001961 |
positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 |
0.2 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) cellular amide catabolic process(GO:0043605) |
0.1 |
7.2 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 |
1.9 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
0.0 |
15.6 |
GO:0098916 |
chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) |
0.0 |
0.8 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
0.0 |
0.3 |
GO:1990592 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 |
0.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
0.0 |
4.6 |
GO:0021915 |
neural tube development(GO:0021915) |
0.0 |
0.7 |
GO:0003094 |
glomerular filtration(GO:0003094) |
0.0 |
5.4 |
GO:0006937 |
regulation of muscle contraction(GO:0006937) |
0.0 |
2.4 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
0.0 |
0.7 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.0 |
0.9 |
GO:0032620 |
interleukin-17 production(GO:0032620) |
0.0 |
2.0 |
GO:0071349 |
interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 |
0.1 |
GO:0035814 |
negative regulation of urine volume(GO:0035811) negative regulation of renal sodium excretion(GO:0035814) |
0.0 |
1.5 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
0.0 |
3.9 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 |
1.2 |
GO:0014047 |
glutamate secretion(GO:0014047) |
0.0 |
21.6 |
GO:0007417 |
central nervous system development(GO:0007417) |
0.0 |
1.0 |
GO:0042552 |
myelination(GO:0042552) |
0.0 |
1.6 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
0.0 |
5.7 |
GO:0045860 |
positive regulation of protein kinase activity(GO:0045860) |
0.0 |
0.1 |
GO:0042953 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 |
0.2 |
GO:1901661 |
quinone metabolic process(GO:1901661) |